의약품 관련 법령
BfArM Information Note: Requirements According to the Falsified Medicines Directive (Directive 2011/62/EC)
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-12-08 | 조회수 | 1,322 |
| 국가정보 | 유럽>독일 | ||
| 출처 | BfArM | ||
| 원문 | www.bfarm.de | ||
| 첨부파일 | |||
BfArM Information Note_ Requirements According to the Falsified Medicines Directive (Directive 2011_62_EC).pdf(214.72KB)
This note provides general information on information on the implementation of the regulatory requirements of the Falsified Medicines Directive.
The document is followed by a joint announcement of Federal Institute for Drugs and Medical Devices, Paul-Ehrlich-Institut and Federal Institute for Vaccines and Biomedical Drugs from 11-Apr-2017 regarding the implementation of the third sentence of Articl...
The document is followed by a joint announcement of Federal Institute for Drugs and Medical Devices, Paul-Ehrlich-Institut and Federal Institute for Vaccines and Biomedical Drugs from 11-Apr-2017 regarding the implementation of the third sentence of Articl...
- 이전글 PEI Information Note: Requirements in Accordance with the Falsified Medicines Directive (Directive 2011/62/EC)
- 다음글 G-BA Information Note: The Benefit Assessment of Pharmaceuticals in Accordance with the German Social Code, Book Five (SGB V), Section 35a
